Wednesday, June 27, 2018

Cancer Gene Therapy - Table of Contents alert Volume 25 Issue 5

If you are unable to see the message below, click here to view.
Cancer Gene Therapy

Volume 25, Issue 5

In this issue
Review Article
Also new

Review Article

CRISPR/Cas9 genome editing technology significantly accelerated herpes simplex virus research

Dong Wang, Xian-Wang Wang, Xiao-Chun Peng, Ying Xiang, Shi-Bao Song et al.

Cancer Gene Therapy 2018 25 :93 - 105; April 25, 2018; 10.1038/s41417-018-0016-3


Abstract | Full Text


Regulated intratumoral expression of IL-12 using a RheoSwitch Therapeutic System® (RTS®) gene switch as gene therapy for the treatment of glioma

John A. Barrett, Hongliang Cai, John Miao, Pranay D. Khare, Paul Gonzalez et al.

Cancer Gene Therapy 2018 25 :106 - 116; May 14, 2018; 10.1038/s41417-018-0019-0


Abstract | Full Text

T-bet promotes potent antitumor activity of CD4+ CAR T cells

Albert T Gacerez & Charles L Sentman

Cancer Gene Therapy 2018 25 :117 - 128; March 07, 2018; 10.1038/s41417-018-0012-7


Abstract | Full Text

Genomic landscape and prognostic analysis of mantle cell lymphoma

Ping Yang, Weilong Zhang, Jing Wang, Yuanyuan Liu, Ran An et al.

Cancer Gene Therapy 2018 25 :129 - 140; May 14, 2018; 10.1038/s41417-018-0022-5


Abstract | Full Text

Magnetic nanoparticle-mediated gene therapy to induce Fas apoptosis pathway in breast cancer

Harun Basoglu, Beyza Goncu & Fahri Akbas

Cancer Gene Therapy 2018 25 :141 - 147; March 29, 2018; 10.1038/s41417-018-0017-2


Abstract | Full Text

Synergistic antitumour effects of rapamycin and oncolytic reovirus

Charles Comins, Guy Richard Simpson, William Rogers, Kate Relph, Kevin Harrington et al.

Cancer Gene Therapy 2018 25 :148 - 160; May 03, 2018; 10.1038/s41417-018-0011-8


Abstract | Full Text

Nature Briefing is an essential round-up of science news, opinion and analysis, free in your inbox every weekday. With Nature Briefing, we'll keep you updated on the latest research, so you can focus on yours.

Click here to sign up.
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on For event advertising opportunities across the Nature Publishing Group portfolio please contact
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Cancer Gene Therapy.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your account at: (You will need to log in to be recognised as a registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature

No comments: